← Alle Unternehmen
Über das Unternehmen
ATANIS Biotech AG has developed a novel functional cell based assay that massively simplifies the diagnosis of allergies and can predict treatment success of therapies. This test is used to assess safety and efficacy of potential new drug candidates for allergy treatment. It is being developed for an upcoming commercialization in the clinic. Contact us at: [email protected]